Osaic Holdings
CORT icon

Osaic Holdings’s Corcept Therapeutics CORT Stock Holding History

Osaic Holdings’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Sell
8,004
-5,189
-39% -$313K ﹤0.01% 3358
2026
Q1 		$532K Sell
13,193
-1,305
-9% -$48.8K ﹤0.01% 3288
2025
Q4 		$504K Sell
14,498
-2,051
-12% -$161K ﹤0.01% 3331
2025
Q3 		$1.19M Sell
16,549
-224
-1% -$16.2K ﹤0.01% 2639
2025
Q2 		$1.32M Buy
16,773
+4,541
+37% +$329K ﹤0.01% 2266
2025
Q1 		$1.4M Sell
12,232
-801
-6% -$48.8K ﹤0.01% 1947
2024
Q4 		$657K Sell
13,033
-2,237
-15% -$117K ﹤0.01% 2545
2024
Q3 		$707K Sell
15,270
-25,435
-62% -$904K ﹤0.01% 2557
2024
Q2 		$1.32M Buy
40,705
+12,406
+44% +$340K ﹤0.01% 1966
2024
Q1 		$713K Buy
28,299
+15,822
+127% +$374K ﹤0.01% 2644
2023
Q4 		$405K Sell
12,477
-5,157
-29% -$142K ﹤0.01% 3339
2023
Q3 		$480K Buy
17,634
+11,095
+170% +$321K ﹤0.01% 3272
2023
Q2 		$146K Sell
6,539
-3,712
-36% -$85.4K ﹤0.01% 4151
2023
Q1 		$222K Buy
10,251
+3,318
+48% +$72.7K ﹤0.01% 3786
2022
Q4 		$141K Buy
6,933
+1,382
+25% +$34.6K ﹤0.01% 4145
2022
Q3 		$142K Buy
5,551
+781
+16% +$20.9K ﹤0.01% 4062
2022
Q2 		$117K Buy
4,770
+923
+24% +$20.1K ﹤0.01% 4281
2022
Q1 		$33K Buy
3,847
+362
+10% +$7.7K ﹤0.01% 5377
2021
Q4 		$70K Sell
3,485
-2,757
-44% -$55.9K ﹤0.01% 4883
2021
Q3 		$124K Sell
6,242
-61
-1% -$1.28K ﹤0.01% 4330
2021
Q2 		$140K Sell
6,303
-5,395
-46% -$120K ﹤0.01% 4194
2021
Q1 		$286K Sell
11,698
-24
-0.2% -$641 ﹤0.01% 3423
2020
Q4 		$306K Buy
11,722
+10,576
+923% +$223K ﹤0.01% 3102
2020
Q3 		$19K Buy
1,146
+248
+28% +$3.95K ﹤0.01% 4932
2020
Q2 		$15K Sell
898
-230
-20% -$3.23K ﹤0.01% 4955
2020
Q1 		$14K Buy
+1,128
New +$14K ﹤0.01% 4827

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's CORT Position: Q2 2026 in Review

Osaic Holdings reduced its Corcept Therapeutics (CORT) stake by 39% in Q2 2026, selling an estimated $313K and leaving 8,004 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #3358.

Osaic Holdings first reported a position in CORT in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.4M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Osaic Holdings held 8,004 shares of Corcept Therapeutics worth $696K as of Q2 2026.
  • Osaic Holdings sold 5,189 Corcept Therapeutics shares in Q2 2026, an estimated $313K.
  • Corcept Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3358 holding.
  • Osaic Holdings first reported a position in Corcept Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Corcept Therapeutics position peaked at $1.4M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.